Your session is about to expire
← Back to Search
Dietary Supplement
High dose Phaeosol group for Cognitive Functioning (PHAEOSOL-TWO Trial)
N/A
Waitlist Available
Led By Richard Kreider, Professor
Research Sponsored by Microphyt
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from week 0 to week 4
Awards & highlights
PHAEOSOL-TWO Trial Summary
Efficacy of a Microalgae Extract PhaeoSOL Combined With Natural Stimulant on Cognitive Function and Gaming Performance of Video Gamers
Eligible Conditions
- Cognitive Functioning
- Video Gaming
PHAEOSOL-TWO Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from week 0 to week 4
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from week 0 to week 4
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Attention shifting
General attention
Reaction time
+1 moreSecondary outcome measures
Eyes irritability
Gaming performance
Global fatigue
+2 morePHAEOSOL-TWO Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Low dose Phaeosol groupExperimental Treatment1 Intervention
1 Phaeosol softgel of 440mg/day and 1 placebo softgel of 440mg/day look like softgel of Phaeosol product) + 1 capsule of 440mg/day of natural stimulant
Group II: High dose Phaeosol groupExperimental Treatment1 Intervention
2 Phaeosol softgels of 440mg/day + 1 capsule of 440mg/day of natural stimulant
Group III: Placebo groupPlacebo Group1 Intervention
2 placebo softgels of 440mg/day (look like softgel of Phaeosol product) + 1 capsule of 440mg/day containing Microcellulose (look like capsule of natural stimulant)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Phaeosol low dose
2021
N/A
~60
Phaeosol high dose
2021
N/A
~60
Find a Location
Who is running the clinical trial?
MicrophytLead Sponsor
4 Previous Clinical Trials
246 Total Patients Enrolled
Texas A&M UniversityOTHER
140 Previous Clinical Trials
24,046 Total Patients Enrolled
1 Trials studying Cognitive Functioning
13 Patients Enrolled for Cognitive Functioning
Richard Kreider, ProfessorPrincipal InvestigatorTexas A&M University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger